Latest Operational Infrastructure News

Murray Cod Australia Ltd reports a landmark FY25 profit turnaround driven by record biomass growth and infrastructure expansion, setting the stage for a commercial inflection in FY26.

Golden Horse Minerals continues to hit high-grade gold intersections at depth in its Hopes Hill project, with drilling activity set to intensify as a fourth rig arrives. New geophysical targets promise further exploration upside.

Tetratherix Limited reported a $9.4 million statutory loss for FY25 amid significant R&D and operational investments, successfully listing on the ASX and progressing multiple clinical and manufacturing initiatives.

Weebit Nano Limited reported a strong FY25 with revenues surging over fourfold to $4.4 million and a narrowed net loss of $38.4 million, driven by key licensing deals and progress towards automotive-grade ReRAM qualification.

Nanosonics delivered a robust FY25 with 17% revenue growth and a 72% jump in profit before tax, propelled by next-gen trophon devices and advancing CORIS commercialisation.

Sayona Mining has significantly increased the Mineral Resource and Ore Reserves at its Moblan Lithium Project in Quebec, reinforcing the project's long-term viability amid rising lithium demand.

Auric Mining has executed a contract to acquire the Burbanks Mill in Western Australia for $4.4 million, marking a strategic step towards operational independence and enhanced value capture.

BPH Global has transitioned from development to early commercial sales in its Indonesian seaweed operations, securing key offtake agreements and advancing multiple R&D projects. The company also raised $609,000 in fresh capital, positioning itself for growth in sustainable biotech markets.

Aspire Mining Limited has refined its Ovoot Coking Coal Project development plans to reduce upfront capital expenditure, progressing towards mining commencement in Q4 2025 amid positive market feedback and advancing infrastructure contracts.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.

Caravel Minerals has initiated the engineering tendering process for its Caravel Copper Project, aiming to award contracts from August 2025. This follows a simplified plant design and a $15 million loan facility, positioning the project for streamlined development.